Treatment of Mediterranean visceral leishmaniasis.
Authors:
- A BrycesonABA Bryceson
- P DesjeuxPDP Desjeux
- 1 January 1995
- journal article
- clinical trial
- Vol. 73 (2) , 191-7
Abstract
Up-to-date information is given on the epidemiological situation of zoonotic visceral leishmaniasis (ZVL) in nine Mediterranean countries, and on drug regimens adopted in the management of ZVL patients in each country. Results of experimental and clinical trials on the efficacy and tolerability of liposomal amphotericin B in laboratory animals and in patients with ZVL are presented, as well as conclusions and recommendations on drug regimens to be used in the treatment of ZVL.Keywords
This publication has 6 references indexed in Scilit:
- The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typingEpidemiology and Infection, 1993
- Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Prevalence of Leishmania infection among AIDS patientsThe Lancet, 1992
- Liposomal amphotericin B in drug-resistant visceral leishmaniasisThe Lancet, 1991